SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

IPSEN SA - AT WEEK 52, 85.3% OF PATIENTS RECEIVING IQIRVO® ACHIEVED NORMALIZATION OF ALP COMPARED WITH 23.3% RECEIVING PLACEBO

IPSEN SA - AT WEEK 52, 85.3% OF PATIENTS RECEIVING IQIRVO® ACHIEVED NORMALIZATION OF ALP COMPARED W

SA

Related stories